Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Amgen Inc.
3120
Amgen Inc.
Amgen engages in the development of human therapeutic products in supportive ofcancer care, inflammation, nephrology and bone diseases.
Suggest edits
Founded
1985
Raised
$12M
Follow us
Companies in the same industry
Cryofocus Biotech
Bamboo Therapeutics
Immatics
ResMed
Invisible Sentinel
Allinaire Therapeutics
bioMerieux
Prota Therapeutics
Regennera
G-CON
Alexa global traffic share
Twitter followers
Overview
News
Investments
34
Portfolio
Portfolio Tracker
Acquisitions
4
Apps
1
Add info
Latest investments
Show all
$10,000,000
Venture capital (Series A)
EnClear Therapies
Seed fund
NAVAN Technologies
Team Size
10000+
Employees
I work here
Location
United States
Headquarters
Explore United States
Geographical Focus
United States
Markets focus
Biotechnology
Past year's investments
3 rounds in the past year
$50M deployed in total
$16.7M avg per round
Latest rounds
EnClear Therapies: Venture capital (Series A) ($10M)
NAVAN Technologies: Seed fund (Undisclosed amount)
IMAGO BIOSCIENCES: Venture capital (Series B) ($40M)
Main Co-investors
Skyline Ventures
United States
GV
United States
Alta Partners
United States
